Sitemap

November 13, 2023 Articles

Filter by Available Specialty
  1. Benralizumab lowers COPD exacerbations in asthma, COPD at 1 year
  2. Bone density decreases when stopping, never using menopausal hormone therapy
  3. Cancer immunotherapy diminishes peak COVID-19 vaccine antibody response
  4. Caregivers of toddlers ‘ready to go’ for peanut oral immunotherapy, yet meet many hurdles
  5. COVID-19 linked to decrease in obstetric intervention, increase in perinatal mortality
  6. COVID-19 rebounds in one in five Paxlovid users
  7. Discussing DED treatment cost can help build trust, lead to more same-day procedures
  8. Durvalumab regimen extends PFS in certain patients with liver cancer
  9. Extended oral tranexamic acid may improve outcomes after TKA
  10. FDA agrees to design of phase 3 trial for choroidal melanoma treatment
  11. Few patients with kidney cancer who meet evaluation criteria receive genetic counseling
  12. Five stories for the start of flu season
  13. Gender gap in life expectancy widens amid COVID-19, drug overdose crisis
  14. Guiding an ‘aesthetically oriented public’ away from loosely regulated medical spas
  15. Hooked on Primary Care with Monique Gary, DO
  16. How behavioral finance impacts physicians’ decision making
  17. Hydroxychloroquine use predicts lower risk for fatty liver disease in rheumatoid arthritis
  18. Intensive BP lowering confers mortality benefit in Asian cohort
  19. Interstitial lung disease can develop ‘in any stage’ of systemic sclerosis
  20. Intervention boosts discussion of out-of-pocket HF drug costs between patients, doctors
  21. Lepodisiran substantially lowers Lp(a) in early trial
  22. Live from AAO Eyecelerator 2023
  23. MASH now top indication for liver transplantation in those with hepatocellular carcinoma
  24. MASH resolution without worsening fibrosis boosts 15-year survival after bariatric surgery
  25. Neurofilament light chain predicted confirmed disability worsening at 1 to 2 years in MS
  26. Nonwhite individuals appear underrepresented in food allergy clinical trials
  27. Obinutuzumab improves odds of complete renal response, cuts flare risk in lupus nephritis
  28. Ora, BlindCAN Film Festival launch Blind Canvas Project, create art inspired by blindness
  29. Physical and mental health measures worse for adults with HF vs. lung, colorectal cancers
  30. Poll: Americans feel better after small acts of kindness
  31. Povorcitinib outperforms placebo as treatment for hidradenitis suppurativa
  32. Pregnant patients with low anti-Ro titers have ‘little to no’ risk for fetal heart block
  33. Prioritize personal health, financial independence on the path to retirement
  34. Provider training alone may not be enough to improve advanced care planning
  35. Q&A: Benefits of pulmonary point-of-care ultrasonography
  36. Q&A: Oral health screening in children
  37. Regular marijuana use linked to risk for HF, major adverse heart, brain events
  38. Researchers estimate global food allergy prevalence using standardized methodology
  39. Screening for peripartum cardiomyopathy using AI-enhanced digital stethoscope shows promise
  40. Several comorbidities found to be independent risk factors for late PJI after TKA
  41. Smartphone-based speech analysis app may predict worsening heart failure
  42. Survey finds neurologists seek to minimize side effects of treatment in Parkinson’s
  43. Survey: Preventing serious reactions comes first in treating children with food allergy
  44. Testosterone treatment boosts hemoglobin levels for older men with anemia
  45. TMP-SMX reduces serious infections ‘by about half’ in patients with GPA using rituximab
  46. Top in cardiology: New options for statin intolerance; heart benefits of Wegovy
  47. Transarterial chemoembolization plus vitamin K enhances anticancer effects on HCC
  48. VIDEO: Biggest treatment challenges for patients with hyperphosphatemia
  49. VIDEO: Deepak L. Bhatt, MD, MPH, highlights new data on semaglutide, tirzepatide at AHA
  50. VIDEO: Drugs in the pipeline for hyperphosphatemia management
  51. VIDEO: Latest treatment advancements in hyperphosphatemia
  52. VIDEO: Progressive pediatric myopia treatment at the tail end of phase 3 clinical trial
  53. VIDEO: Unmet needs of patients with hyperphosphatemia
  54. Zanzalintinib a potential ‘novel breakthrough’ in advanced clear cell renal cell carcinoma